We are live on ! Find out more
CI

Canerector Inc Portfolio holdings

AUM $219M
1-Year Est. Return 39.57%
This Fund
S&P 500
This Quarter Est. Return
+19.24%
1 Year Est. Return
+39.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$219M
AUM Growth
+$8.12M
Cap. Flow
+$19.3M
Cap. Flow %
8.82%
Top 10 Hldgs %
100%
Holding
9
New
Increased
3
Reduced
Closed

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$10.7M
2
MKL icon
Markel Group
MKL
+$5.35M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$3.23M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 84.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOO icon
1
Vanguard S&P 500 ETF
VOO
$1.02T
$34.3M 15.67%
50,000
+4,850
+11% +$3.23M
MFC icon
2
Manulife Financial
MFC
$72B
$32.4M 14.77%
800,000
BNS icon
3
Scotiabank
BNS
$107B
$26M 11.87%
300,000
BRK.B icon
4
Berkshire Hathaway Class B
BRK.B
$1.06T
$25M 11.42%
50,000
+22,360
+81% +$10.7M
TD icon
5
Toronto Dominion Bank
TD
$193B
$24.3M 11.07%
200,000
CM icon
6
Canadian Imperial Bank of Commerce
CM
$106B
$23M 10.49%
200,000
BMO icon
7
Bank of Montreal
BMO
$121B
$22.1M 10.06%
125,000
MKL icon
8
Markel Group
MKL
$22.2B
$16.6M 7.57%
8,500
+2,865
+51% +$5.35M
RY icon
9
Royal Bank of Canada
RY
$289B
$15.5M 7.07%
75,000

Similar funds

Canerector Inc's Q2 2026 Portfolio in Review

As of Q2 2026, Canerector Inc held 9 positions worth $219M, up 3.8% from $211M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Canerector Inc deployed $19.3M of net new capital in Q2 2026, adding to 3 existing holdings.

By sector, the portfolio is most concentrated in Financials at 84% of assets, down from 87% a quarter earlier.

  • Canerector Inc added most to Berkshire Hathaway Class B in Q2 2026, an estimated $10.7M increase.
  • Canerector Inc's ten largest holdings make up 100% of its $219M portfolio in Q2 2026.
  • Canerector Inc opened 0 new positions and closed 0 in Q2 2026.
  • Canerector Inc's portfolio value rose 3.8% quarter-over-quarter to $219M.

Based on Canerector Inc's 13F filing for Q2 2026, filed 7 Aug 2026.